MENU
+Compare
IRWD
Stock ticker: NASDAQ
AS OF
Jun 26, 04:59 PM (EDT)
Price
$0.77
Change
+$0.02 (+2.67%)
Capitalization
1.36B

IRWD Ironwood Pharmaceuticals Forecast, Technical & Fundamental Analysis

Ironwood Pharmaceuticals Inc is a specialty and generic drug manufacturing company that operates a human therapeutics segment... Show more

IRWD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for IRWD with price predictions
Jun 25, 2025

IRWD sees its Stochastic Oscillator recovers from oversold territory

On June 18, 2025, the Stochastic Oscillator for IRWD moved out of oversold territory and this could be a bullish sign for the stock. Traders may want to buy the stock or buy call options. Tickeron's A.I.dvisor looked at 55 instances where the indicator left the oversold zone. In of the 55 cases the stock moved higher in the following days. This puts the odds of a move higher at over .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where IRWD's RSI Oscillator exited the oversold zone, of 36 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for IRWD just turned positive on May 20, 2025. Looking at past instances where IRWD's MACD turned positive, the stock continued to rise in of 44 cases over the following month. The odds of a continued upward trend are .

IRWD moved above its 50-day moving average on June 24, 2025 date and that indicates a change from a downward trend to an upward trend.

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where IRWD advanced for three days, in of 260 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 154 cases where IRWD Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on June 25, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on IRWD as a result. In of 95 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where IRWD declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

IRWD broke above its upper Bollinger Band on June 10, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. IRWD’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.266) is normal, around the industry mean (62.463). P/E Ratio (10.309) is within average values for comparable stocks, (89.614). IRWD's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.987). Dividend Yield (0.000) settles around the average of (0.122) among similar stocks. P/S Ratio (3.027) is also within normal values, averaging (19.198).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. IRWD’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock worse than average.

View a ticker or compare two or three
IRWD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

IRWD is expected to report earnings to fall 91.79% to -1 cents per share on August 07

Ironwood Pharmaceuticals IRWD Stock Earnings Reports
Q2'25
Est.
$-0.01
Q1'25
Missed
by $0.10
Q4'24
Missed
by $0.04
Q3'24
Missed
by $0.05
Q2'24
Missed
by $0.17
The last earnings report on May 07 showed earnings per share of -14 cents, missing the estimate of -3 cents. With 1.49M shares outstanding, the current market capitalization sits at 1.36B.
A.I. Advisor
published General Information

General Information

a developer of innovative human medicines

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
100 Summer Street
Phone
+1 617 621-7722
Employees
267
Web
https://www.ironwoodpharma.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FIRTX10.05N/A
N/A
Fidelity Advisor Intl Real Estate M
NEXTX33.08N/A
N/A
Shelton Sustainable Equity Investor
IDVSX27.80N/A
N/A
Morgan Stanley Inst Intl Advtg R6
GBLFX39.06-0.04
-0.10%
American Funds Global Balanced F2
MSMIX30.30-0.13
-0.43%
NYLI WMC Value Investor Class

IRWD and Stocks

Correlation & Price change

A.I.dvisor tells us that IRWD and ACET have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that IRWD and ACET's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IRWD
1D Price
Change %
IRWD100%
+3.20%
ACET - IRWD
30%
Poorly correlated
+0.58%
PRGO - IRWD
29%
Poorly correlated
-0.49%
ASRT - IRWD
26%
Poorly correlated
-0.91%
ELAN - IRWD
24%
Poorly correlated
+1.85%
HROW - IRWD
24%
Poorly correlated
-0.50%
More